Outlook Therapeutics, Inc. (OTLK)
NASDAQ·Healthcare·Biotechnology
$0.26
-8.28%
Mkt Cap $11.72M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 17, 2026 | $3.14M | -$1.21M | -138.44% | -$0.17 | -$0.22 | -29.41% | — | — |
| Q4 2025 Dec 19, 2025 | $5.84M | -$91.79K | -101.57% | -$0.26 | -$0.22 | +15.38% | — | — |
| Q3 2025 Aug 14, 2025 | $5.85M | $1.51M | -74.25% | -$0.42 | -$0.44 | -4.76% | — | — |
| Q2 2025 May 15, 2025 | $702.60K | — | — | -$0.55 | -$0.40 | +27.27% | — | — |
| Q1 2025 Feb 14, 2025 | $702.60K | — | — | -$0.85 | -$0.89 | -4.71% | — | — |
| Q4 2024 Dec 27, 2024 | — | — | — | -$0.83 | -$0.77 | +7.23% | — | — |
| Q3 2024 Aug 14, 2024 | — | — | — | -$1.06 | -$0.83 | +21.70% | — | — |
| Q2 2024 May 15, 2024 | — | — | — | -$0.88 | -$1.55 | -76.14% | — | — |
| Q1 2024 Feb 14, 2024 | — | — | — | -$1.00 | -$0.80 | +20.00% | — | — |
| Q4 2023 Dec 22, 2023 | $2.49M | — | — | -$1.00 | -$1.00 | +0.00% | — | — |
| Q3 2023 Aug 14, 2023 | $2.18M | — | — | -$0.80 | -$1.60 | -100.00% | — | — |
| Q2 2023 May 15, 2023 | — | — | — | -$1.20 | -$0.60 | +50.00% | — | — |
| Q1 2023 Feb 14, 2023 | — | — | — | -$0.80 | -$1.60 | -100.00% | — | — |
| Q4 2022 Dec 29, 2022 | — | — | — | -$0.07 | -$0.06 | +14.29% | — | — |
| Q3 2022 Aug 10, 2022 | — | — | — | -$1.60 | -$1.60 | +0.00% | — | — |
| Q2 2022 May 13, 2022 | — | — | — | -$1.40 | -$1.80 | -28.57% | — | — |
| Q1 2022 Feb 14, 2022 | — | — | — | -$1.40 | -$1.60 | -14.29% | — | — |
| Q4 2021 Dec 22, 2021 | — | — | — | -$1.40 | -$1.60 | -14.29% | — | — |
| Q3 2021 Aug 13, 2021 | $320.00K | — | — | -$1.60 | -$1.40 | +12.50% | — | — |
| Q2 2021 May 14, 2021 | $320.00K | — | — | -$2.20 | -$1.80 | +18.18% | — | — |